Results 181 to 190 of about 8,320 (205)
Some of the next articles are maybe not open access.

Cimetidine—an Antifibrinolytic Agent?

Scandinavian Journal of Gastroenterology, 1983
The mucosal fibrinolytic activity was estimated in 14 patients with duodenal ulcer before and after 4 weeks' treatment with cimetidine. A significant reduction in fibrinolytic activity in the corpus and antrum mucosa was found after treatment. In patients with healed ulcer after treatment, the activity was lower than in patients with unhealed ulcers ...
openaire   +3 more sources

The Antifibrinolytic Properties of Cimetidine

Scandinavian Journal of Gastroenterology, 1986
The mucosal fibrinolytic activity was estimated in 24 patients with duodenal ulcer and in 11 patients with gastric ulcer. The fibrinolytic activity was estimated in biopsy specimens taken during gastroscopy. Specimens were taken in the corpus, in the antrum, and in the duodenal mucosa.
openaire   +3 more sources

Antifibrinolytics for heavy menstrual bleeding

Cochrane Database of Systematic Reviews, 2000
Heavy menstrual bleeding (HMB) is an important cause of ill health in women. Medical therapy, with the avoidance of possibly unnecessary surgery, is an attractive treatment option. A wide variety of medications are available to reduce heavy menstrual bleeding but there is considerable variation in practice and uncertainty about the most appropriate ...
I, Cooke, A, Lethaby, C, Farquhar
openaire   +3 more sources

Antifibrinolytics in women with menorrhagia

Thrombosis Research, 2011
Heavy menstrual bleeding is associated with increased local fibrinolysis. Antifibrinolytic agents have been used in women with menorrhagia with and without bleeding disorders, and have been demonstrated to decrease menstrual blood flow approximately 50% and improve quality of life.
openaire   +3 more sources

Antifibrinolytic Activity of Certain Pectins

Thrombosis and Haemostasis, 1961
SummaryIngestion of wine and beer, but not of ethyl alcohol, produced a decrease of the blood fibrinolytic activity. In vitro experiments showed that wine and beer contained a principle which inhibited fibrinolytic activators. This principle was isolated from grape pulp, and upon analysis it was found to be a pectin-like substance.
Inga Marie Nilsson   +3 more
openaire   +3 more sources

Antifibrinolytics in Subarachnoid Hemorrhage

Archives of Neurology, 1987
Few conditions evince potential for disaster or cure as vividly as subarachnoid hemorrhage. If the patient survives the initial bleeding intact or with minor deficits, clipping of the aneurysm virtually eliminates the risk of recurrence. However, before something definite can be done, the patient faces the risk of rebleeding and later that of vasospasm.
openaire   +3 more sources

Antifibrinolytic Therapy-Reply

Archives of Neurology, 1982
In Reply.— We thank Dr Vermeulen and his associates for their comments. The effectiveness of antifibrinolytic therapy has not been unequivocally proved. The whole subject has been recently reviewed. 1 Much of the controversy about the value of antifibrinolytic therapy has resulted from problems in methods. None of the studies (including ours), whether
A. L. Sahs   +2 more
openaire   +2 more sources

Antifibrinolytic properties of basic proteins

Experientia, 1972
In-vitro-Versuche uber basische Eiweisskorper zeigen, dass Protamine und Histone in die Struktur des unter Thrombin-Einfluss entstehenden Fibrins eingebaut werden. Einbau basischer Proteine fuhrt zur Anderung der Fibrinstruktur und zur Widerstandserhohung auf die Plasminwirkung.
Rzeczycki W, Farbiszewski R, Worowski K
openaire   +3 more sources

Antifibrinolytic Therapy for Intracranial Aneurysms

Journal of Neurosurgery, 1968
I T HAS long been known and it has been recently documented in an admirable fashion 7 that patients who sustain a subarachnoid hemorrhage from a ruptured berry aneurysm have a tendency to rebleed, that this tendency is minimal during the first 2 days, rises to a maximum about the end of the first week, falls to a relatively low level during the third ...
J Dawley, S Mullan
openaire   +3 more sources

Antifibrinolytic agents in subarachnoid haemorrhage

Journal of Neurology, 1987
For many years clinicians have used antifibrinolytic agents to try to reduce rebleeding after subarachnoid haemorrhage. Early studies of their effectiveness produced conflicting results. This paper re-evaluates the available trials and considers benefits in the light of potential complications.
openaire   +2 more sources

Home - About - Disclaimer - Privacy